$30 Million: Major Biotech Company Secures Genetic Research Investment

MeiraGTx Secures $30 Million Investment from Sanofi, Eyes Further Strategic Opportunities.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In an exciting development for the biotechnology sector, MeiraGTx Holdings plc (Nasdaq: MGTX), a leading genetic medicines company, has announced a strategic investment of $30 million from global healthcare le…